How many studies have been conducted on Meglumine?

BiohacksAI has indexed 300 PubMed studies on Meglumine, including 36 randomized controlled trials (RCTs). 34% of studies involve human subjects.

What are the main research areas for Meglumine?

The primary research domains for Meglumine are 🔬 Inflammation, ⏳ Longevity & Aging, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Meglumine

A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium.

300+ PubMed studies analyzed · 36 RCTs · Evidence Score: 45.7

Research Domains

Meglumine has been studied across 17 research domains including 🔬 Inflammation, ⏳ Longevity & Aging, 🔬 Oncology, 🧠 Focus & Attention, 🫘 Kidney. The primary research focus is 🔬 Inflammation with 23% of studies addressing this area.

Loading evidence profile...

This evidence profile for Meglumine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.